The results of these studies were in line with our findings, which indicated that in patients with IIM, the presence of isolated anti-Ro-52 antibody positivity was associated with a more than eight-fold increased risk of developing ILD. This evidence concerns the gene TRIM21 and acquired idiopathic inflammatory myopathy.